Información del producto
MSDC-0602 is a novel antidiabetic drug that has been shown to inhibit the uptake of glucose by adipose tissues. This drug also stimulates mitochondrial function and increases the capacity of human liver cells to metabolize fatty acids. MSDC-0602 is currently in clinical trials for use in patients with hepatic steatosis, diabetes, or cancer. It is hoped that this drug will be effective against these diseases due to its ability to increase the uptake of glucose by liver cells and adipose tissues and its stimulation of mitochondrial function.
Propiedades químicas
Consulta técnica sobre: 3D-IVB81987 MSDC-0602
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
